PROREGEN: Early phase 1 study started recruiting, 300 planned (Musculoskeletal Diseases or Conditions)
PROREGEN: Early phase 1 study started recruiting, 300 planned (Musculoskeletal Diseases or Conditions). Its enrollment of 300 is above the median of 80 (83rd percentile). Dated 49 days ago, it serves as a historical benchmark. Score 45/100. As of 2026-11-04, from ClinicalTrials.gov (U.S. National Library of Medicine) API v2.
Data as of · Compiled by Zalwin from ClinicalTrials.gov (U.S. National Library of Medicine) API v2
enrollment: 300 · 83th percentile of 8,879 ClinicalTrialStartPulse records · 3.8x the median
Free preview: all 15 published fields of this record are shown below. Locked: 499 related ClinicalTrialStartPulse records and the 7-column CSV export.
| Field | Value |
|---|---|
| Sponsor | PROREGEN |
| Sponsor type | Research network |
| Study | Orthobiological Therapies in Musculoskeletal Disorders |
| NCT ID | NCT07434115 |
| Phase | Early phase 1 |
| Status | recruiting |
| Conditions | Musculoskeletal Diseases or Conditions |
| Intervention types | biological |
| Target enrollment | 300 |
| Site countries | Brazil |
| Posted | 2026-02-25 |
| Planned start | 2026-09-16 |
| Event | Started recruiting |
| Event date | 2026-09-16 |
| Last update posted | 2026-09-17 |
| enrollment percentile | 83th of 8,879 (median 80, 3.8x median) |
| Peer records CSV (500 records) | 🔒 Click to unlock → |
| CRM-ready export with official source URLs | 🔒 Click to unlock → |
Watch PROREGEN
Free email alert. Alert me when this company gets a new filing, lien, permit, contract or expiry in this feed. One confirmation email; unsubscribe any time.
Free for 1 company. More companies from $9/mo (25), $49/mo (500 + CSV), $199/mo (500 + CSV + API). Cancel any time from the link in every email.
Free first: a 10-record sample of records
See the real columns before you buy. One confirmation email, nothing else unless you opt in.
Unlock PROREGEN + 500 peer records (CSV)
Instant CSV download · Card, Apple Pay, Google Pay or Link via Stripe · No account required
CSV columns: Sponsor · Phase · Conditions · Enrollment · Countries · Event · Posted · official source URL
- Source agency: ClinicalTrials.gov (U.S. National Library of Medicine) API v2
- Record date: 2026-09-17
- Data refreshed: 2026-11-04
- Refunds on request within 14 days
Top ClinicalTrialStartPulse records (NONUS first): University of Oxford · DejthidaNathaphong · Eye & ENT Hospital of Fudan University · Shanghai First Maternal and Infant Health Hospital affiliate · Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Browse all by state and category →
LIVE PUBLIC DATA Source: ClinicalTrials.gov (U.S. National Library of Medicine) API v2 · Last refreshed: Wed, 04 Nov 2026 06:04:38 GMT
Is this your business? Add a "Listed on Zalwin" badge to your site
Paste this snippet into your website. It links to this public record; nothing is tracked on your site.
Peer benchmark and outreach value: PROREGEN and 6,603 NONUS peers
- NONUS ClinicalTrialStartPulse records like this one: 6,603
- PROREGEN's enrollment: 83rd percentile of 8,879 records
- Timing: Low: older than 30 days
- Estimated pipeline if you contact every NONUS peer: $1,320,600 (peers × rate × deal size; an estimate from your assumptions, not a forecast)
45 / 100 Score
- Just started recruiting: sites, recruitment and supply are active.
- 300 participants planned.
What is the ClinicalTrialStartPulse record for PROREGEN?
PROREGEN's Early phase 1 study (NCT07434115) in Musculoskeletal Diseases or Conditions, first posted 2026-02-25: started recruiting (2026-09-16), in an update posted 2026-09-17.
How does PROREGEN compare to other ClinicalTrialStartPulse records?
Its enrollment of 300 sits in the upper half (83th percentile) of 8,879 records; the median is 80. It is 49 days old; check the official source for later updates before acting.
PROREGEN vs. top 2 peers
| Organization | Location | Amount | Percentile | Record date |
|---|---|---|---|---|
| PROREGEN | NONUS | 300 | 83rd | 2026-09-17 |
| Atridia Pty Ltd. | NONUS | 101 | 60th | 2026-10-14 |
| Eye & ENT Hospital of Fudan University | NONUS | 30 | 19th | 2026-11-02 |
Related records
ClinicalTrialStartPulse: Early phase 1 ClinicalTrialStartPulse: Outside the US only ClinicalTrialStartPulse: 300+
How to monitor PROREGEN and peer early phase 1 records
Get new ClinicalTrialStartPulse records like PROREGEN by email (free, weekly)
We email one confirmation link now; the weekly digest starts only after you confirm. One-click unsubscribe in every email.
Double opt-in: nothing is sent until you click the confirmation link. One-click unsubscribe.
Get new studies in your therapeutic areas
ClinicalTrialStartPulse emails new studies and status changes matching your events, phases, sponsor types and site regions.
✓ Read-only, live public data · Key and unlock right after payment · Card, Apple Pay, Google Pay or Link via Stripe · Refunds on request within 14 days
From public ClinicalTrials.gov registrations. Sponsor and study level only: we never list investigators, contacts or participants. A registration describes a planned study and can change. Status changes are read from each study's current status, actual dates and latest posted update, not a full change history, so an update can be a correction rather than a new change. Verify on ClinicalTrials.gov.